• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

KML-B 处理的树突状细胞通过诱导淋巴细胞活化的抗肿瘤作用。

Antitumor Effect of KML-B-Treated Dendritic Cells via Induction of Lymphocyte Activation.

机构信息

Singapore Bioimaging Consortium, Agency for Science, Technology and Research, 11 Biopolis Way, No. 02-02 Helios, Singapore 138667.

Department of Pharmacy, Sunchon National University, 255 Jungangno, Suncheon 540-950, Republic of Korea.

出版信息

J Immunol Res. 2017;2017:2471627. doi: 10.1155/2017/2471627. Epub 2017 May 29.

DOI:10.1155/2017/2471627
PMID:28634588
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5467341/
Abstract

Lectins are carbohydrate-binding proteins with various biological activities, such as antitumor and immunomodulatory effects. Although lectins have various biological activities, they are still limited by cytotoxicity in normal cells. To overcome this problem, we used the noncytotoxic part of Korean mistletoe lectin B-chain (KML-B) to induce maturation of dendritic cells (DCs). A previous study reported that KML-B induces DC maturation by triggering TLR-4, including expression of costimulatory molecules (CD40, CD80, and CD86), MHC II, and secretion of cytokines in DCs. Additionally, matured DCs by KML-B induced T helper (Th) cell activation and differentiation toward Th1 cells. However, the interaction of KML-B-treated DCs with CD8 T cells is still poorly understood. In this study, we confirmed the ability of matured DCs by KML-B to stimulate cytotoxic T cells using OT-1 mouse-derived CD8 T cells. KML-B induced MHC I expression in DCs, stimulation of CD8 T cell activation and proliferation, and IFN- secretion. Moreover, tumor sizes were reduced by KML-B treatment during vaccination of OVA-pulsed DCs. Here, we confirmed induction of CD8 T cell activation and the antitumor effect of KML-B treatment in DCs.

摘要

凝集素是具有多种生物活性的碳水化合物结合蛋白,如抗肿瘤和免疫调节作用。尽管凝集素有多种生物活性,但它们在正常细胞中仍受到细胞毒性的限制。为了克服这个问题,我们使用韩国槲寄生凝集素 B 链(KML-B)的非细胞毒性部分诱导树突状细胞(DC)成熟。先前的研究表明,KML-B 通过触发 TLR-4 诱导 DC 成熟,包括共刺激分子(CD40、CD80 和 CD86)、MHC II 和 DC 中细胞因子的分泌。此外,KML-B 诱导的成熟 DC 可诱导 T 辅助(Th)细胞向 Th1 细胞激活和分化。然而,KML-B 处理的 DC 与 CD8 T 细胞的相互作用仍知之甚少。在这项研究中,我们使用 OT-1 小鼠来源的 CD8 T 细胞证实了 KML-B 成熟 DC 刺激细胞毒性 T 细胞的能力。KML-B 在 DC 中诱导 MHC I 表达,刺激 CD8 T 细胞活化和增殖,并分泌 IFN-。此外,在 OVA 脉冲 DC 接种时,KML-B 治疗可减小肿瘤大小。在这里,我们证实了 KML-B 在 DC 中诱导 CD8 T 细胞活化和抗肿瘤作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10d0/5467341/82223f7ed9f1/JIR2017-2471627.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10d0/5467341/c08e0f8e2ff4/JIR2017-2471627.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10d0/5467341/cc42820a77c4/JIR2017-2471627.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10d0/5467341/f9fdd1c6d889/JIR2017-2471627.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10d0/5467341/82223f7ed9f1/JIR2017-2471627.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10d0/5467341/c08e0f8e2ff4/JIR2017-2471627.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10d0/5467341/cc42820a77c4/JIR2017-2471627.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10d0/5467341/f9fdd1c6d889/JIR2017-2471627.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10d0/5467341/82223f7ed9f1/JIR2017-2471627.004.jpg

相似文献

1
Antitumor Effect of KML-B-Treated Dendritic Cells via Induction of Lymphocyte Activation.KML-B 处理的树突状细胞通过诱导淋巴细胞活化的抗肿瘤作用。
J Immunol Res. 2017;2017:2471627. doi: 10.1155/2017/2471627. Epub 2017 May 29.
2
Enhanced dendritic cell maturation by the B-chain of Korean mistletoe lectin (KML-B), a novel TLR4 agonist.新型TLR4激动剂——韩国槲寄生凝集素B链(KML-B)增强树突状细胞成熟
Int Immunopharmacol. 2014 Aug;21(2):309-19. doi: 10.1016/j.intimp.2014.05.010. Epub 2014 May 21.
3
Interferon gamma stimulates cellular maturation of dendritic cell line DC2.4 leading to induction of efficient cytotoxic T cell responses and antitumor immunity.干扰素γ刺激树突状细胞系DC2.4的细胞成熟,从而诱导有效的细胞毒性T细胞反应和抗肿瘤免疫。
Cell Mol Immunol. 2007 Apr;4(2):105-11.
4
CD40-independent natural killer-cell help promotes dendritic cell vaccine-induced T-cell immunity against endogenous B-cell lymphoma.不依赖CD40的自然杀伤细胞辅助作用可促进树突状细胞疫苗诱导的针对内源性B细胞淋巴瘤的T细胞免疫。
Int J Cancer. 2014 Dec 15;135(12):2825-33. doi: 10.1002/ijc.28932. Epub 2014 May 8.
5
Vaccination with dendritic cells pulsed in vitro with tumor antigen conjugated to cholera toxin efficiently induces specific tumoricidal CD8+ cytotoxic lymphocytes dependent on cyclic AMP activation of dendritic cells.用与霍乱毒素偶联的肿瘤抗原在体外脉冲处理的树突状细胞进行疫苗接种,可有效诱导依赖树突状细胞环磷酸腺苷激活的特异性杀肿瘤CD8 + 细胞毒性淋巴细胞。
Clin Immunol. 2004 Jul;112(1):35-44. doi: 10.1016/j.clim.2004.03.001.
6
The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.细胞因子基因共转导对使用表达肿瘤相关抗原的基因修饰树突状细胞进行癌症疫苗治疗的增强作用。
Int J Oncol. 2006 Apr;28(4):947-53.
7
Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.接受树突状细胞免疫治疗的乳腺癌Balb/C小鼠淋巴结中树突状细胞和T细胞的表型特征
Immunol Lett. 2016 Sep;177:25-37. doi: 10.1016/j.imlet.2016.07.009. Epub 2016 Jul 14.
8
Strategies for antigen loading of dendritic cells to enhance the antitumor immune response.用于树突状细胞抗原负载以增强抗肿瘤免疫反应的策略。
Cancer Res. 2002 Mar 15;62(6):1884-9.
9
Sialic acid removal from dendritic cells improves antigen cross-presentation and boosts anti-tumor immune responses.从树突状细胞中去除唾液酸可改善抗原交叉呈递并增强抗肿瘤免疫反应。
Oncotarget. 2016 Jul 5;7(27):41053-41066. doi: 10.18632/oncotarget.9419.
10
Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines.肿瘤细胞裂解物脉冲处理的人树突状细胞诱导针对胰腺癌细胞的T细胞反应:一种评估肿瘤疫苗的体外模型。
Cancer Res. 2001 Sep 1;61(17):6445-50.

引用本文的文献

1
A fermented Mistletoe (Viscum album L.) extract elicits markers characteristic for immunogenic cell death driven by endoplasmic reticulum stress in vitro.一种发酵的槲寄生(欧洲槲寄生)提取物在体外引发了由内质网应激驱动的免疫原性细胞死亡的特征性标志物。
BMC Complement Med Ther. 2025 May 14;25(1):175. doi: 10.1186/s12906-025-04909-8.
2
Enhanced anti-tumor immunotherapy by silica-coated magnetic nanoparticles conjugated with ovalbumin.通过与卵清蛋白结合的硅涂层磁性纳米颗粒增强抗肿瘤免疫治疗。
Int J Nanomedicine. 2019 Oct 16;14:8235-8249. doi: 10.2147/IJN.S194352. eCollection 2019.
3
Enhanced anti-tumor immunotherapy by dissolving microneedle patch loaded ovalbumin.

本文引用的文献

1
Enhanced dendritic cell maturation by the B-chain of Korean mistletoe lectin (KML-B), a novel TLR4 agonist.新型TLR4激动剂——韩国槲寄生凝集素B链(KML-B)增强树突状细胞成熟
Int Immunopharmacol. 2014 Aug;21(2):309-19. doi: 10.1016/j.intimp.2014.05.010. Epub 2014 May 21.
2
CD4 T-cell subsets and tumor immunity: the helpful and the not-so-helpful.CD4 T 细胞亚群与肿瘤免疫:有益与无益。
Cancer Immunol Res. 2014 Feb;2(2):91-8. doi: 10.1158/2326-6066.CIR-13-0216.
3
Effect of gamma irradiation on mistletoe (Viscum album) lectin-mediated toxicity and immunomodulatory activity.
通过溶解负载卵清蛋白的微针贴片增强抗肿瘤免疫治疗。
PLoS One. 2019 Aug 6;14(8):e0220382. doi: 10.1371/journal.pone.0220382. eCollection 2019.
γ 射线辐照对槲寄生(Viscum album)凝集素介导的毒性和免疫调节活性的影响。
FEBS Open Bio. 2013 Jan 22;3:106-11. doi: 10.1016/j.fob.2013.01.003. Print 2013.
4
Mushroom lectin enhanced immunogenicity of HBV DNA vaccine in C57BL/6 and HBsAg-transgenic mice.蘑菇凝集素增强 HBV DNA 疫苗在 C57BL/6 和 HBsAg 转基因小鼠中的免疫原性。
Vaccine. 2013 Apr 26;31(18):2273-80. doi: 10.1016/j.vaccine.2013.02.062. Epub 2013 Mar 13.
5
TLR agonists: our best frenemy in cancer immunotherapy.TLR 激动剂:癌症免疫治疗中的最佳友敌。
J Leukoc Biol. 2013 Jun;93(6):847-63. doi: 10.1189/jlb.1012501. Epub 2013 Mar 8.
6
The immunomodulatory effect of plant lectins: a review with emphasis on ArtinM properties.植物凝集素的免疫调节作用:综述重点介绍 ArtinM 性质。
Glycoconj J. 2013 Oct;30(7):641-57. doi: 10.1007/s10719-012-9464-4. Epub 2013 Jan 9.
7
Immuno-oncology: understanding the function and dysfunction of the immune system in cancer.免疫肿瘤学:了解免疫系统在癌症中的功能和失调。
Ann Oncol. 2012 Sep;23 Suppl 8(Suppl 8):viii6-9. doi: 10.1093/annonc/mds256.
8
Cancer immunotherapy via dendritic cells.通过树突状细胞进行癌症免疫疗法。
Nat Rev Cancer. 2012 Mar 22;12(4):265-77. doi: 10.1038/nrc3258.
9
Immune microenvironments in solid tumors: new targets for therapy.实体瘤中的免疫微环境:治疗的新靶点。
Genes Dev. 2011 Dec 15;25(24):2559-72. doi: 10.1101/gad.169029.111.
10
Enhanced efficacy of therapeutic cancer vaccines produced by co-treatment with Mycobacterium tuberculosis heparin-binding hemagglutinin, a novel TLR4 agonist.结核分枝杆菌肝素结合血凝素(一种新型 TLR4 激动剂)联合治疗可增强治疗性癌症疫苗的疗效。
Cancer Res. 2011 Apr 15;71(8):2858-70. doi: 10.1158/0008-5472.CAN-10-3487. Epub 2011 Mar 2.